This enduring microburst education summarizes the highlights from the Live education held during AAD 2025. The focus is dermatologists and oncologists ability to integrate immunotherapy into the neoadjuvant treatment of patients with nonmelanoma skin cancer, now and as the treatment paradigm evolves. As a result of this educational curriculum, learners should be better able to: 1. Review the clinical significance of the latest efficacy data for neoadjuvant immunotherapy in nonmelanoma skin cancer; 2. Select patients with nonmelanoma skin cancer who might benefit from neoadjuvant immunotherapy; 3. Discuss strategies to manage immune-related adverse events in the neoadjuvant setting; and, 4. Outline practical, multidisciplinary strategies to incorporate immunotherapy into neoadjuvant treatment plans for patients with nonmelanoma skin cancer. Learners have the ability to download slides and podcast for use in clinical practice.
- Provider:Answers in CME Inc. (AiCME)
- Activity Link: https://www.answersincme.com/GJZ
- Start Date: 2025-03-31 05:00:00
- End Date: 2025-03-31 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: Regeneron Pharmaceuticals, Inc. - Amount: 76869.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all